Results 41 to 50 of about 35,539 (289)

Genetic diversity of the mumps viruses (Paramyxoviridae: Orthorubulavirus: Mumps orthorubulavirus): an overview

Вопросы вирусологии, 2022
Mumps is an infectious disease controlled by specific vaccine prophylaxis. To date, its social and epidemiological significance remains high. This is evidenced by the process of developing and implementing into the health care practices of many countries
T. S. Chekhlyaeva, D. V. Erokhov, I. Yu. Andrievskaya, P. E. Zherdeva, N. T. Tikhonova   +4 more
doaj   +1 more source

Mumps Outbreak at a University and Recommendation for a Third Dose of Measles-Mumps-Rubella Vaccine - Illinois, 2015-2016.

MMWR. Morbidity and mortality weekly report, 2016
Mumps is an acute viral disease characterized by fever and swelling of the parotid or other salivary glands. On May 1, 2015, the Illinois Department of Public Health (IDPH) confirmed a mumps outbreak at the University of Illinois at Urbana-Champaign ...
J. Albertson, W. Clegg, Heather D Reid, Benjamin S. Arbise, J. Pryde, Awais Vaid, Rachella Thompson-Brown, Fredrick Echols   +7 more
semanticscholar   +1 more source

THE RESULTS OF STUDY OF THE LEVELS OF SPECIFIC ANTIBODIES TO THE COMBINED INJECTION VACCINES AGAINST INFLUENZA, MEASLES, RUBELLA AND MUMPS AND DT IN CHILDREN WITH CHRONIC PHYSICAL ILLNESS

Детские инфекции (Москва), 2015
The levels of antibodies to the separate and combined administration of the vaccine plus Grippol® Plus and vaccines against measles, mumps and/or rubella, diphtheria and tetanus (DT) in children with chronic medical illnesses, including HIV and organic ...
S. M. Haritе, A. A. Ruleva, O. V. Goleva, O. S. Kalinogorskaya, V. A. Apryatina   +4 more
doaj   +1 more source

Mumps Virus Nucleoprotein and Hemagglutinin-Specific Antibody Response Following a Third Dose of Measles Mumps Rubella Vaccine

Open Forum Infectious Diseases, 2017
Background Recent mumps outbreaks among 2-dose measles mumps rubella (MMR) vaccine recipients have raised questions regarding the potential benefits of a third dose of vaccine (MMR3).
D. Latner, Amy Parker Fiebelkorn, M. McGrew, Nobia J. Williams, L. Coleman, H. McLean, S. Rubin, C. Hickman   +7 more
semanticscholar   +1 more source

Unilateral Optic Neuritis: A Rare Complication after Measles-Mumps-Rubella Vaccination in a 30-Year-Old Woman

Case Reports in Ophthalmological Medicine, 2016
Purpose. To report a case of unilateral optic neuritis following Measles-Mumps-Rubella (MMR) vaccination. Methods. A 30-year-old female developed unilateral optic neuritis five days after a Measles-Mumps-Rubella (MMR) booster vaccination.
Chiara De Giacinto, Elvira Guaglione, Pia E. Leon, Rossella D’Aloisio, Odilla Vattovani, Giuseppe Ravalico, Daniele Tognetto   +6 more
doaj   +1 more source

Immunological Protection Against Vaccine-Preventable Infections (Hepatitis B, Measles, Rubella, Mumps, Diphtheria, Tetanus) of Russian and Foreign Students: A Simultaneous Study

Педиатрическая фармакология, 2020
The increase in the incidence of vaccine-preventable infections is due to the low level of immunological protection of the population, which against the background of active migration processes can determine high risks of outbreaks of infectious diseases
Diana V. Sutovskaya, Alla V. Burlutskaya, Larisa V. Dubova, Daria R. Krylova, Olga G. Korobkina   +4 more
doaj   +1 more source

Using Real-Time RT-PCR Reagent Kits for Identity Testing of Measles, Mumps and Rubella Vaccines

Биопрепараты: Профилактика, диагностика, лечение, 2018
Currently, the identity of measles, mumps and rubella virus vaccines is determined during certification testing by a labour-consuming, lengthy and costly neutralisation test using cell cultures.
A. S. Binyatova, E. D. Mytsa, N. V. Chertova, R. A. Volkova, K. A. Sarkisyan, T. N. Ilyasova, T. N. Yunasova, A. A. Movsesyants, V. A. Merkulov   +8 more
doaj   +1 more source

The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertiary Centre study

Pediatric Rheumatology Online Journal, 2021
Background Immunosuppressive drugs, incomplete vaccine coverage, immune system dysregulation might be factors of a low level of anti-vaccine antibodies in JIA patients. The study aimed to evaluate vaccine coverage, post-vaccine immunity, and risk factors
Mikhail M. Kostik, Natalia A. Lubimova, Irina V. Fridman, Olga V. Goleva, Susanna M. Kharit   +4 more
doaj   +1 more source

Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I/II clinical trial

Human Vaccines & Immunotherapeutics, 2019
Domestic measles, mumps, and rubella combined (MMR) vaccines were discontinued in 1993 in Japan because of the unexpected high incidence of aseptic meningitis. The introduction of an effective MMR vaccine with lower reactogenicity has been expected.
Tetsuo Nakayama, Masahiro Eda, Motonori Hirano, Wakako Goto   +3 more
doaj   +1 more source

Immunogenicity and Safety of a Novel MMR Vaccine (Live) (Freeze-dried): Results of a Phase II Clinical Trial [PDF]

Journal of Clinical and Diagnostic Research, 2018
Introduction: This is the first study in Indian paediatric subjects to evaluate the novel Measles, Mumps and Rubella (MMR) vaccine developed by M/s Cadila Healthcare Limited, India, containing the Hoshino mumps strain.
Rajesh Joshi, Neeta Hanumante, Uma Nayak, Shalaka Agarkhedkar, Paresh Thakkar, Jayesh Sanmukhani, Ravindra Mittal   +6 more
doaj   +1 more source